Table 1.
Epidemiologic, clinical, and biological characteristics of the 2 groups.
| Transdermal DHT | Testosterone Enanthate | P value | |
|---|---|---|---|
| Number of patients | 27 | 22 | |
| Age at consultation (Years) | 8.4 ± 3.7 | 10 ± 3.4 | .1 |
| Medical and familial history | No | No | |
| Initial size of micropenis (Cm) | 2.9 ± 0.7 cm (−2.42 SD) | 3 ± 0.9 cm (−2.2 SD) | .74 |
| Mean of FSH (mUi/ml) | 3.1 ± 2 | 1.3 ± 0.9 | .29 |
| Mean of LH (mUi/ml) | 3.4 ± 1 | 1.4 ± 1 | .44 |
| Mean of Testosterone (ng/ml) | 0.12 ± 0.1 | 0.23 ± 0.15 | .29 |
Abbreviations: SD, standard deviation; Cm, centimeters; FSH, follicle stimulating hormone; LH, luteinizing hormone.